Alkaline Phosphatase (ALP) Isoenzyme Interpretation in the Athlete Clinical Workup: Why a Mildly Elevated Total ALP on a Routine Panel Is a Bone-Remodeling Signal Until the Paired GGT and the Bone-Specific ALP Say Otherwise, the Loading-Phase and Growth-Plate Context That Explains the Lift, and the SOAP Structure That Carries the Finding Into the Bone-Health, Training-Load, and Hepatology-Referral Branches of the Plan
A 17-year-old female high school cross-country runner arrives at the sports RD with a pre-season physical panel returning a total alkaline phosphatase of 142 U/L against a laboratory reference bracket upper bound of 115 U/L. The pediatric-sports-medicine ordering physician flagged the reading as "mildly elevated ALP, repeat in six weeks, consider hepatology referral if persistent." The athlete, her coach, and the parents arrived at the intake session asking whether the training plan, the oral contraceptive pill she started three months prior, or an occult hepatobiliary disease was the driver of the lift. The read is almost certainly a bone-remodeling signal. The adolescent growth plate is open, the peak-height-velocity window has not yet closed in a sizable fraction of 17-year-old female runners, and bone-specific ALP (BSAP) — the osteoblast-derived isoenzyme — contributes between 40 and 70 percent of total serum ALP in the adolescent population against an adult reference of approximately 40 to 50 percent. The paired marker that reads the hepatobiliary signal against the bone-remodeling signal is the gamma-glutamyl transferase (GGT), a hepatobiliary-exclusive enzyme that does not rise with bone-driven ALP elevations. This is the ALP isoenzyme interpretation guide for the sports RD: the four-isoenzyme biology (bone, liver, intestinal, placental) that drives the total-ALP reading, the paired GGT read that separates the hepatic from the bone signal without ordering a direct isoenzyme fractionation, the bone-specific ALP (BSAP) direct-measurement option when the GGT read is ambiguous, the age-and-training-phase context that explains the loading-phase and growth-spurt elevation patterns, the four intake presentations that earn the ordered workup rather than the reflexive hepatology referral, and the SOAP structure that carries the finding into the bone-health, training-load, and hepatology-referral branches of the plan.
A 17-year-old female high school cross-country runner presents at a pre-season intake with the sports RD. The athlete is three weeks into an 18-week cross-country build, is coming off a consultation with the pediatric sports medicine group that cleared her for the season against the pre-participation physical, and brings the forwarded laboratory panel the pediatrician ran at the visit. The panel reads inside the laboratory reference bracket on the complete metabolic panel (BUN 12 mg/dL, creatinine 0.7 mg/dL, eGFR >90 mL/min/1.73 m², sodium 140, potassium 4.1, chloride 104, bicarbonate 25), inside the reference bracket on the aspartate aminotransferase (AST 22 U/L) and the alanine aminotransferase (ALT 18 U/L), inside the reference bracket on the total bilirubin (0.6 mg/dL) and the albumin (4.2 g/dL), and returns a total alkaline phosphatase of 142 U/L against a laboratory reference bracket upper bound of 115 U/L for the adult female reference range the laboratory report printed on the panel. The pediatric-sports-medicine ordering note flagged the reading as "mildly elevated ALP, repeat in six weeks, consider hepatology referral if persistent," and the family arrived at the intake session visibly concerned, asking whether the training plan, the oral contraceptive pill the athlete had started three months prior for menstrual-cycle regulation, or an occult hepatobiliary disease was the driver of the lift.
The read is defensible against the laboratory reference bracket that was printed on the report. The problem is the reference bracket. The adult-female reference range the laboratory applied to the 17-year-old adolescent panel does not carry the age-stratified pediatric reference-bracket shift that the adolescent-growth-plate biology generates on the total-ALP reading. Total serum alkaline phosphatase is the sum of four isoenzymes — the bone-specific ALP (BSAP) derived from osteoblast activity, the liver ALP derived from the hepatobiliary canaliculi, the intestinal ALP from the brush-border enterocytes, and the placental ALP active in the pregnant population. In the 17-year-old female population, the bone-isoenzyme contribution runs between 40 and 70 percent of total ALP against an adult-female reference of approximately 40 to 50 percent, with the lift driven by the open growth plate, the active mineralization of the epiphyseal cartilage, the peak-height-velocity biology that has not closed in a non-trivial fraction of the 17-year-old female running population, and the additional loading-phase remodeling the three-week pre-season-build mileage ramp drives on the osteoblast compartment. The pediatric reference bracket for total ALP in the 15-to-17-year-old female population extends to approximately 170 to 200 U/L depending on the laboratory and the assay platform — well above the 142 U/L reading the panel returned. The occupational-reference-applied read generated a false-alarm elevation flag against a reference bracket that did not correspond to the age of the patient.
The marker that separates the bone-isoenzyme signal from the hepatic-isoenzyme signal on the total-ALP read — the gamma-glutamyl transferase (GGT), a hepatobiliary-exclusive enzyme that rises with cholestatic liver disease and does not rise with bone-driven ALP elevations — is the one paired test the sports RD orders before the family sits in a pediatric hepatology waiting room on a reference-bracket false alarm. This is the alkaline phosphatase isoenzyme interpretation guide for the sports RD: the four-isoenzyme biology that drives the total-ALP reading, the paired GGT read that separates the hepatic from the bone signal without a direct isoenzyme fractionation, the bone-specific ALP (BSAP) direct-measurement option when the GGT read is ambiguous, the age-and-training-phase context that explains the loading-phase and growth-spurt elevation patterns, the four intake presentations that earn the ordered workup, and the SOAP structure that carries the finding into the bone-health, training-load, and hepatology-referral branches of the plan.
The Four-Isoenzyme Biology of Total Serum ALP
Alkaline phosphatase is a hydrolase enzyme family that cleaves phosphate monoesters at alkaline pH, and the serum compartment carries four distinct tissue-specific isoenzymes that aggregate into the single total-ALP reading the standard chemistry panel reports.
Bone-specific ALP (BSAP). Derived from the osteoblast. The enzyme hydrolyzes inorganic pyrophosphate at the bone-mineralization front, releasing the phosphate substrate that combines with calcium to form the hydroxyapatite crystal matrix the osteoid takes on in the final mineralization step of bone formation. Serum BSAP rises during any phase of accelerated bone formation: the adolescent growth-plate biology (highest contribution in the pre-and-peri-pubertal window, tapering through the late teens as the growth plates close), the post-fracture callus-remodeling phase (elevated across the 6-to-12-week post-fracture window, higher and longer in the long-bone fracture population), the training-induced bone-loading remodeling (elevated across the first 8 to 12 weeks of a volume-ramp build in the previously detrained or lower-mileage population), the vitamin-D-replacement response in the deficient athlete (elevated across the 4-to-8-week re-mineralization window after D3 repletion), the pregnancy and the lactation windows, and the Paget's disease and the fibrous dysplasia pathologies at the extreme end of the differential. The bone isoenzyme is the single largest contributor to the pediatric total-ALP reading and the single most common driver of the mild-to-moderate total-ALP elevation in the trained-athlete population.
Liver ALP. Derived from the hepatobiliary canaliculi, the biliary-ductule epithelial cells, and the sinusoidal hepatocyte membrane. Serum liver ALP rises during cholestatic hepatobiliary disease — the extrahepatic obstructions (choledocholithiasis, biliary stricture, pancreatic head mass, primary sclerosing cholangitis), the intrahepatic cholestasis syndromes (primary biliary cholangitis, drug-induced cholestasis, infiltrative hepatic disease including sarcoidosis and amyloidosis and metastatic disease), and the inducible-liver-ALP elevations driven by enzyme-inducing medications (anti-epileptics, estrogen-based oral contraceptives in a narrow fraction of users, specific anti-fungals). The liver isoenzyme is the isoenzyme the standard liver-function-panel interpretation structure assumes against the total-ALP reading when the clinical context carries a hepatobiliary signal, and it is the isoenzyme the sports RD has to differentiate from the bone isoenzyme when the total-ALP reading rises in the training-phase-ramp or growth-spurt context without a hepatobiliary signal on the paired AST, ALT, bilirubin, or GGT.
Intestinal ALP. Derived from the brush-border enterocytes of the small intestine. Serum intestinal ALP rises transiently after a high-fat meal in the ABO blood-group B and O population with the secretor-positive phenotype (the biology that generates the postprandial lift reads as a 1.5-to-2-fold rise in the intestinal fraction across the 2-to-6-hour postprandial window) and is persistently mildly elevated in the inflammatory bowel disease, celiac disease, and cirrhosis populations. The intestinal isoenzyme is a minor contributor to total ALP in the fasting adult population and a non-trivial contributor to the non-fasting adult total-ALP reading, and the sports RD confirming a fasting draw on the total-ALP measurement closes the intestinal-isoenzyme contribution against the clean-read interpretation.
Placental ALP. Derived from the placental trophoblast. Elevated across the second and third trimesters of pregnancy, with the term reading reaching approximately 2-to-4-fold the non-pregnant reference bracket. The placental isoenzyme is a contributor to the pregnant-athlete total-ALP reading and does not contribute to the non-pregnant population.
The clinical consequence for the sports RD is that the total-ALP reading on the standard panel is a sum across four isoenzymes with distinct tissue-source signatures, and the elevation flag against the laboratory reference bracket is not interpretable as a hepatobiliary signal without the paired read that separates the bone and the hepatic contributions.
The GGT as the Hepatobiliary Isoenzyme Separator
Gamma-glutamyl transferase (GGT) is a hepatobiliary-canalicular membrane-bound enzyme that catalyzes the transfer of the gamma-glutamyl group from glutathione to amino-acid acceptors at the biliary-ductule epithelium. GGT is derived from the same hepatobiliary-canalicular compartment that generates the liver-ALP isoenzyme and rises with the same cholestatic insults that drive the liver-ALP lift. The biological consequence is that the GGT and the liver-ALP are concordant on the cholestatic signal and the GGT is a tissue-specific hepatobiliary marker that does not rise with bone-driven ALP elevations.
The paired read against the elevated total ALP structures as follows.
Elevated total ALP with normal GGT. The read consistent with a bone-isoenzyme-driven total-ALP elevation. The differential opens across the age-and-training-phase bracket (adolescent growth-plate, pre-season training-load-ramp remodeling, post-fracture callus phase, vitamin-D-replacement response) against the pediatric and the athletic population, and the sports RD anchors the bone-health workup and the training-load context without a hepatology referral. The expected clinical trajectory in the trained athlete on a ramp build reads as a gradual decline to the baseline across the 8-to-12-week post-ramp window as the osteoblast compartment transitions out of the acute-remodeling phase.
Elevated total ALP with elevated GGT. The read consistent with a liver-isoenzyme-driven total-ALP elevation or a mixed bone-and-liver pattern. The differential opens against the cholestatic hepatobiliary differential and the inducible-liver-ALP differential (oral contraceptive, anti-epileptic exposure, specific anti-fungal exposure), and the sports RD coordinates the hepatobiliary workup (abdominal ultrasound to screen for biliary dilation, paired AST/ALT/bilirubin trend, drug-exposure reconciliation against the oral-contraceptive and the anti-epileptic exposures) alongside the hepatology referral if the trend persists across the 6-week redraw.
Normal total ALP with elevated GGT. The read consistent with an isolated hepatobiliary-induction signal without a cholestatic structural disease — the alcohol-use pattern (GGT is a sensitive marker for heavy alcohol exposure across the preceding 2-to-4-week window, and the female-athlete population carries a documented binge-drinking prevalence inside a non-trivial fraction of the competitive endurance population), the chronic hepatic-steatosis pattern, the inducible-enzyme medication-exposure pattern, and the diabetic-liver-involvement pattern. The sports RD opens the alcohol-use screening (AUDIT-C), the metabolic-syndrome workup (fasting glucose, HbA1c, lipid panel against the hepatic-steatosis differential), and the medication-exposure reconciliation against the identified pattern.
The Bone-Specific ALP (BSAP) Direct Measurement Option
The paired GGT is sufficient to separate the bone from the hepatic signal in the majority of intake presentations. The direct bone-specific ALP measurement (BSAP, sometimes reported as bone-ALP or ostase against the specific-assay commercial name) is the second-order test the sports RD orders in the narrow fraction of presentations where the paired GGT read is ambiguous (a borderline-elevated GGT on an athlete with a confirmed pre-season-ramp training phase, or a mildly elevated total ALP in a context where the parallel oral-contraceptive exposure confounds the GGT interpretation).
The BSAP is a direct immunoassay of the bone isoenzyme against a monoclonal antibody specific to the osteoblast-derived ALP fraction. The result reads in U/L against an age-and-sex-specific reference bracket, and the interpretive structure reads: BSAP above the reference bracket confirms the bone-isoenzyme contribution as the driver of the total-ALP elevation (and the sports RD anchors the bone-health workup and the training-load context against the bone-remodeling signal), while BSAP inside the reference bracket against an elevated total ALP flags the non-bone contribution (and the sports RD extends the hepatobiliary workup against the structural or inducible hepatic signal independent of the GGT ambiguity).
The BSAP measurement additionally serves as a serial-tracking marker for the bone-formation side of the paired bone-turnover-marker panel against the CTX (C-telopeptide, the bone-resorption marker) and the P1NP (procollagen type I N-terminal propeptide, the alternative bone-formation marker) reads. The BSAP is less sensitive to acute training-load phase shifts than the P1NP against a 6-week serial-tracking window but carries a longer half-life and a stronger age-stratified reference-bracket data set in the pediatric and the perimenopausal populations the sports RD serves against the bone-turnover-marker workflow.
The Age-and-Training-Phase Context That Explains the Elevation
The sports RD reads the total-ALP elevation against five context variables that structure the pre-test probability of the bone-isoenzyme-driven versus the liver-isoenzyme-driven signal.
Age bracket. The pediatric-and-adolescent population (ages 10 to 17 in males, 9 to 15 in females) carries the open-growth-plate biology that lifts the baseline total-ALP into the 150-to-350 U/L range depending on the assay platform, with the peak reading at the peak-height-velocity window and the taper reading across the two-to-three years before the growth plates close on the lower extremity and the one-to-two years before closure on the vertebral epiphyses. The adult population (ages 20 to 50) carries a reference bracket of approximately 40 to 115 U/L against a bone-fraction contribution of approximately 40 to 50 percent. The perimenopausal-and-postmenopausal female population (ages 50-plus) carries a reference-bracket shift upward driven by the accelerated bone-turnover signal of the estrogen-withdrawal phase, with the bone-fraction contribution rising to approximately 60 to 70 percent against the heightened osteoclast-driven remodeling and the compensatory osteoblast-driven formation.
Training-phase context. The volume-ramp build phase (first 8 to 12 weeks of a pre-season or a return-from-detraining build) drives the bone-loading remodeling signal against the osteoblast compartment and lifts the BSAP reading in the previously detrained athlete. The maintenance-phase and the peaking-phase training structures do not generate the acute-remodeling signal at the same magnitude, and the total-ALP reading in the maintenance-phase or the peaking-phase athlete reads inside the adult reference bracket in the vast majority of asymptomatic presentations.
Recent fracture or stress-injury history. The 6-to-12-week post-fracture window drives the callus-remodeling signal against the BSAP, with the trajectory peaking at approximately 4 to 6 weeks post-fracture and tapering across the 12-to-16-week window. The stress-reaction and the stress-fracture history carries a less-pronounced but reliably detectable BSAP lift across the parallel window.
Vitamin-D replacement phase. The repletion phase in the deficient athlete (serum 25-hydroxyvitamin-D rising from the sub-20-ng/mL bracket into the adequate 30-to-50-ng/mL bracket under D3 supplementation) drives a BSAP lift across the 4-to-8-week post-repletion window as the previously-mineralization-blocked osteoid is actively mineralized against the newly adequate vitamin-D substrate. The BSAP reading returns to the baseline across the subsequent 8-to-12-week window.
Medication exposure. The oral-contraceptive exposure (combined estrogen-progestin formulations) drives a mild inducible liver-ALP signal in a narrow fraction of users. The anti-epileptic exposure (phenytoin, carbamazepine, phenobarbital) drives a more-pronounced inducible liver-ALP signal and additionally drives a vitamin-D-metabolism-accelerated bone-turnover signal that compounds across both isoenzymes. The specific anti-fungal exposures (azole class) drive an inducible hepatic signal that reads on both the GGT and the liver-ALP.
The Four Intake Presentations That Earn the Ordered Workup
Any athlete who arrives with a laboratory-reference-bracket-flagged total-ALP elevation on a routine or a pre-participation panel without a paired GGT or a bone-specific ALP on the same panel. The sports RD orders the paired GGT (and additionally the BSAP if the age-and-training-phase context carries a high pre-test probability of a mixed signal or the athlete is on an oral contraceptive or an anti-epileptic exposure) before the family or the athlete sits in a hepatology waiting room on a reference-bracket false alarm. The pre-visit coaching script reads: "The paired GGT separates the bone from the hepatic signal on the total-ALP reading, the bone-isoenzyme contribution runs between 40 and 70 percent in your age bracket, and the bone-remodeling signal from your pre-season training ramp is the single most likely driver of the lift."
Any athlete presenting with a documented stress reaction, stress fracture, or long-bone fracture within the preceding 16 weeks. The paired BSAP against the baseline serves as a serial-tracking marker for the callus-remodeling trajectory across the return-to-sport window and anchors the bone-health rebuild against the paired CTX and the P1NP reads at the 6-and-12-week recovery milestones.
Any athlete with a documented vitamin-D deficiency (25-hydroxyvitamin-D below 20 ng/mL) entering a D3-repletion protocol. The paired BSAP at the 6-and-12-week post-repletion windows anchors the mineralization-response read against the repletion protocol and confirms the osteoblast-compartment activation against the newly adequate vitamin-D substrate.
Any adolescent athlete transitioning out of the peak-height-velocity window (approximately ages 14 to 17 in females, ages 15 to 18 in males) with a documented history of low bone-mineral density, a family history of osteoporosis, or a longitudinal menstrual-dysfunction pattern in the female athlete. The paired BSAP against the baseline anchors the bone-formation-side read across the critical pre-adult-bone-mass-accrual window and structures the longitudinal file against the RED-S-and-bone-health workup.
The SOAP Documentation
My structure on the presenting cross-country runner vignette reads: "Seventeen-year-old female high-school cross-country runner, week 3 of an 18-week pre-season build at 32 miles weekly volume with one long-run day and one tempo day per week. Pre-participation physical panel from pediatric sports medicine group returned complete metabolic panel inside laboratory reference bracket (BUN 12, creatinine 0.7, eGFR >90, electrolytes normal), AST 22 U/L, ALT 18 U/L, total bilirubin 0.6, albumin 4.2, total alkaline phosphatase 142 U/L against the laboratory-printed adult-female reference bracket upper bound of 115 U/L. Ordering note returned 'mildly elevated ALP, repeat in six weeks, consider hepatology referral if persistent.' Athlete three months into an estrogen-progestin oral contraceptive for menstrual-cycle regulation, no anti-epileptic exposure, no anti-fungal exposure, no documented recent fracture or stress-reaction history, no documented hepatobiliary symptoms (no right-upper-quadrant pain, no pruritus, no jaundice, no dark urine or pale stool), no documented alcohol-use pattern. Draws ordered today: gamma-glutamyl transferase (GGT) via hospital reference lab on fasting morning draw; paired bone-specific alkaline phosphatase (BSAP) direct immunoassay given the oral-contraceptive exposure that confounds the paired GGT interpretation; 25-hydroxyvitamin-D given the pre-season-ramp context and the female-athlete bone-health population; serum calcium, phosphate, and intact PTH to anchor the paired bone-health panel; and a baseline CTX and P1NP for the paired bone-turnover-marker read against the subsequent 6-week serial-tracking draw. Expected turnaround 3 to 5 business days. Working rationale: the total-ALP reading of 142 U/L against the laboratory-printed adult-female reference bracket is inside the pediatric-reference-bracket range for a 17-year-old female (typical upper bound 170 to 200 U/L depending on the assay platform), the age-bracket biology carries the open-growth-plate contribution to the bone-isoenzyme fraction, the three-week pre-season-ramp training-phase context drives the additional bone-loading remodeling signal against the osteoblast compartment, the paired AST, ALT, total bilirubin, and albumin reads inside the laboratory reference bracket without a hepatobiliary signal on the function markers, the oral-contraceptive exposure confounds the paired GGT read in a narrow fraction of users, and the direct BSAP measurement carries the bone-isoenzyme-specific signal against the ambiguous GGT read on the oral-contraceptive-exposed athlete. Plan: panel returning Tuesday or Wednesday; GGT read against the reference bracket (concordant-elevated signal opens the hepatobiliary differential, inside-bracket signal closes the hepatic read); BSAP read against the age-and-training-phase bracket (above-bracket signal confirms the bone-isoenzyme contribution and anchors the bone-remodeling read, inside-bracket signal flags the non-bone contribution and extends the hepatobiliary workup independent of the GGT); 25-hydroxyvitamin-D read against the 30-to-50-ng/mL adequate-range bracket with repletion opened at the sub-30 reading; serum calcium, phosphate, and PTH read against the paired bone-health panel; baseline CTX and P1NP anchors the longitudinal bone-turnover file across the career-arc read. Six-week follow-up draw scheduled regardless of the current panel to establish the longitudinal baseline and the training-phase trajectory. If BSAP returns above the age-bracket reference and GGT returns inside the reference bracket, the bone-remodeling signal is confirmed, the hepatology referral is canceled, the bone-health coaching plan opens (calcium-and-vitamin-D adequacy against the 1300-mg-daily-calcium and the 600-IU-daily-vitamin-D adolescent-female targets, the menstrual-cycle-regulation workup paired with the sports gynecology referral given the oral-contraceptive exposure against the possible underlying RED-S differential, and the training-load coaching plan continues at the scheduled volume with the pre-season-build-to-peak transition timing anchored at the 12-week-ramp-exit window). If BSAP returns inside the reference bracket and GGT returns above the reference bracket, the hepatobiliary workup is extended against the oral-contraceptive-exposed differential with the abdominal ultrasound for biliary dilation and the alcohol-use screening paired with the AUDIT-C, and the training plan is held at the current volume pending the imaging and the hepatology clearance. If both BSAP and GGT return above the reference bracket, the mixed-signal differential opens with the hepatology referral and the parallel bone-health workup, and the training plan is held pending the referral clearance. If both BSAP and GGT return inside the reference bracket against a persistently elevated total ALP, the direct ALP-isoenzyme-fractionation electrophoresis is ordered to separate the intestinal-isoenzyme contribution against the non-fasting-draw confound, and the fasting-draw repeat confirms the clean-read interpretation."
The assessment line names the pattern as "laboratory-reference-bracket-misapplied total-ALP elevation at 142 U/L in a 17-year-old female cross-country runner in week 3 of a pre-season volume ramp consistent with the bone-isoenzyme-driven pediatric-reference-bracket signal pending paired GGT and direct BSAP against the oral-contraceptive-exposure-confounded GGT read" rather than "elevated alkaline phosphatase of unknown etiology — hepatology referral." The plan line specifies the paired GGT and the direct BSAP as the mechanism-clarification instruments that gate the hepatology-referral decision, the paired bone-health panel (25-hydroxyvitamin-D, calcium, phosphate, PTH, baseline CTX and P1NP) as the parallel-read anchoring instruments, and the bone-health coaching intervention as the training-phase-aligned optimization that opens independent of the referral-decision pathway. The intervention opens on day one against the correct interpretation, cancels the unnecessary hepatology referral where the paired reads confirm the bone-remodeling pattern, and anchors the longitudinal baseline against the career-arc read regardless of the current-draw result.
The Follow-Up Cadence
Paired-marker redraw at 6 weeks post-current-draw. The 6-week redraw against the paired GGT, BSAP, 25-hydroxyvitamin-D, calcium, phosphate, PTH, CTX, and P1NP confirms the trajectory against the current-draw baseline and anchors the longitudinal file against the bone-turnover-marker framework. The pre-season and post-season annual draws thereafter maintain the baseline against the single sports-nutrition-controlled bone-health screening endpoint.
Paired-marker redraw at 12 weeks post-fracture or post-stress-reaction. The 12-week post-insult BSAP against the baseline reads the callus-remodeling-trajectory tail and anchors the return-to-full-loading clearance against the identified recovery timeline.
Hepatology referral at any confirmed liver-isoenzyme-driven total-ALP elevation (BSAP inside-bracket, GGT elevated, paired ALT/AST/bilirubin trend consistent with a hepatobiliary signal) that persists across the 6-week redraw. The referral opens the clearance pathway at the correct severity threshold against the broader hepatobiliary-pathology differential the sports RD does not independently work up.
Sports-gynecology referral at any adolescent female athlete with the confirmed bone-isoenzyme-driven total-ALP elevation against a documented menstrual-dysfunction pattern or an oral-contraceptive exposure that masks the underlying menstrual-cycle signal. The parallel RED-S workup and the bone-health longitudinal file anchor the career-arc read against the critical pre-adult-bone-mass-accrual window.
Where Calsanova Fits
The ALP isoenzyme-interpretation workflow depends on the intake carrying the age-and-training-phase context capture that structures the pre-test probability of the bone-isoenzyme-driven versus the liver-isoenzyme-driven signal, the age-stratified pediatric-reference-bracket adjustment that reads the adolescent total-ALP against the correct reference range rather than the laboratory-printed adult reference, the paired-marker ordering framework (GGT, BSAP, 25-hydroxyvitamin-D, calcium, phosphate, PTH, CTX, P1NP) that separates the bone from the hepatic signal and anchors the paired bone-health panel, the medication-exposure reconciliation that reads the oral-contraceptive, the anti-epileptic, and the anti-fungal exposures against the GGT-induction differential, the SOAP template pre-populated against the bone-remodeling versus hepatobiliary differential and the paired bone-health-coaching-plus-training-load-optimization intervention plan, and the longitudinal file that anchors the career-arc trajectory read across the pre-season, post-season, post-fracture, and post-repletion draws. Calsanova's clinical intake carries the age-and-training-phase context capture that triggers the paired-marker recommendation on any total-ALP elevation arriving in the forwarded panels, the age-stratified pediatric-reference-bracket adjustment that reads the adolescent panel against the correct reference range, the paired-marker interpretive module that reads the GGT and the BSAP against the bone-and-hepatic-differential framework with reference-threshold flagging and the paired-bone-health-panel annotation, the SOAP template pre-populated against the bone-remodeling-versus-hepatobiliary differential and the paired bone-health-coaching-plus-training-load-optimization intervention plan, the longitudinal bone-turnover-marker file that tracks the baseline across the pre-season and post-season annual draws, and the hepatology-referral workflow that opens at the correct severity threshold with the paired BSAP-plus-GGT context and the medication-exposure reconciliation pre-attached to the referring communication.
Ready to move your sports-nutrition clinical workflow into a purpose-built system? [Try Calsanova free for 30 days](/signup?role=dietitian) — no credit card, HIPAA-ready from day one, and the ALP isoenzyme interpretation workup runs cleanly against the age-and-training-phase context capture, the paired GGT-plus-BSAP ordering framework, the pediatric-reference-bracket adjustment, the paired bone-health panel, the SOAP template, and the longitudinal file that catches the real hepatobiliary signal while canceling the unnecessary hepatology referrals that the adult-reference-bracket-misapplied random-panel workflow generates against the pediatric and the loading-phase trained-athlete populations.
Ready to modernize your practice?
Calsanova gives dietitians AI-powered meal planning, food recognition, video consultations, and HIPAA-compliant infrastructure.
Start your free trialGet more like this.
Evidence-based writing on nutrition, performance, and the research behind what actually works. No spam, no daily emails — just the good stuff.
Written by Nelson Marques, MS, RD, LD — a registered dietitian and performance nutrition specialist. Founder of Calsanova. More about Nelson
More from the Classroom
1,25-Dihydroxyvitamin D vs 25-Hydroxyvitamin D in the Athlete Clinical Workup: Why the Active-Form Assay Reads the Calcium-Demand-Driven Up-Regulation the Storage-Form Trajectory Does Not See, the Four Paired-Draw Patterns That Classify the Vitamin D Endocrine Axis, the Four Athlete-Population Presentations That Earn the Ordered Paired Draw, and the SOAP Structure That Carries the Finding Into the Dietary, Bone-Health, and Sports-Endocrinology-Referral Branches of the Plan
A 28-year-old female collegiate cross-country runner at week 11 of a 16-week outdoor track build presents with a four-week plateau on her 5k pace, muscle soreness extending into day three after her hard sessions, a 24-hour recall log at 1,800 kcal against an estimated 2,400 kcal need, a cycle gap at eight weeks, and a 25-hydroxyvitamin D of 42 ng/mL drawn at her annual physical. The storage-form vitamin D reads replete against both the Endocrine Society and Institute of Medicine reference brackets. The clinician reads the panel as vitamin D sufficient. The persistent symptom complex, the cycle disruption, and the low-energy-availability pattern on the log tell the sports RD the vitamin D endocrine axis is not readable from the 25-OH-D alone. The marker that reads the calcium-demand-driven activation of the renal 1-alpha-hydroxylase — 1,25-dihydroxyvitamin D, calcitriol, the active hormonal form — is the one the sports RD pairs with the storage marker on the next draw. This is the paired 25-OH-D plus 1,25-DH-D interpretation guide for the sports RD: the storage-vs-hormone biology that drives the dissociated read, the Endocrine Society and active-form reference brackets, the four paired-draw patterns that classify the vitamin D endocrine axis, the four athlete-population presentations that earn the ordered paired draw, the paired-panel assembly against the calcium-phosphate-PTH-FGF-23 axis, the SOAP structure that carries the finding into the dietary, bone-health, and sports-endocrinology-referral branches of the plan, and the eight-to-twelve-week follow-on redraw cadence that tracks the recovery trajectory against the pattern-specific intervention.
November 17, 2026
Bone Turnover Markers (Serum CTX and P1NP) in the Sports RD Workup: Why the Paired Resorption-and-Formation Panel Catches the Active Bone-Loss Signal DXA Reads Six Months Late, the Draw-Protocol Discipline That Controls the Diurnal and Meal-State Variance the Standard Reference Ranges Ignore, and the SOAP Assessment Structure That Documents the Coupled-Uncoupled Read So the Referral Starts at the Right Question
A 22-year-old female collegiate cross-country runner presents to the sports RD on referral with two consecutive tibial stress reactions on the same tibia across the last twelve months, a DXA from three months ago flagged 'within reference for age,' a computed energy availability of 33 kcal/kg FFM/day, a serum 25-hydroxyvitamin D of 38 ng/mL, and a regular menstrual cycle. The referring note reads 'rule out low energy availability and calcium/vitamin D intake.' The DXA is not wrong — it is the wrong tool for the question the presenting picture is asking. DXA integrates bone-mineral-density history across many months to years of prior turnover; it cannot see what the athlete's remodeling coupling is doing this week or this training block. Two consecutive stress reactions on the same tibia in twelve months is the signal that the resorption-formation coupling has shifted toward net resorption, and the paired serum C-terminal telopeptide (CTX) and procollagen type 1 N-terminal propeptide (P1NP) panel is the workup that catches it at the intervention window that still reverses cleanly. This is the bone-turnover-marker interpretation guide for the sports RD: what CTX and P1NP actually measure and why they read a real-time signal DXA cannot, the fasted-morning-no-recent-training-same-lab-same-assay draw-protocol discipline that controls the diurnal and meal-state variance the reference ranges quietly absorb, the four intake presentations that should trigger the paired panel regardless of the DXA read, the coupled-versus-uncoupled interpretation framework that separates the healthy loaded skeleton from the LEA-driven or hypogonadism-driven net-resorption pattern, the SOAP assessment structure that documents the coupling read so the endocrinology or sports-medicine referral starts at the correct question, and the paired energy-availability-plus-mechanical-loading intervention loop the sports RD holds across the 12-to-16-week reassessment cadence.
September 3, 2026
IGF-1 and IGFBP-3 in the Athlete Clinical Workup: Why the Spot IGF-1 Alone Misses the Hepatic GH-Resistance Signature of Low Energy Availability, the Computed Molar Ratio That Reads the Ternary-Complex Biology, the Four Paired-Draw Patterns That Classify the GH-IGF-1 Axis, and the SOAP Structure That Carries the Finding Into the Energy-Availability, Training-Load, and Sports-Endocrinology-Referral Branches of the Plan
A 20-year-old female NCAA Division I distance swimmer presents at week 14 of a 22-week championship build with a six-week plateau on her 200-meter freestyle splits, a 1.2-kilogram loss of DXA-measured fat-free mass, a luteal-phase deficiency on a four-month basal-body-temperature chart, a 24-hour recall log at 2,100 kcal against an estimated 2,750-kcal need, and a team-physician-ordered IGF-1 that returned 215 ng/mL. The laboratory report flags the value as within the age-decade reference bracket and the ordering physician's chart note reads IGF-1 normal, no further endocrine workup indicated. The spot IGF-1 reads the panel as reassuring. The integrated growth-hormone-IGF-axis signal that is actually driving the plateau is not readable from the IGF-1 alone. The marker that reads the hepatic GH-resistance signature against the dominant binding-protein pool, insulin-like growth factor binding protein 3 (IGFBP-3), and the computed IGF-1/IGFBP-3 molar ratio that reads against the ternary-complex biology are the two reads the sports RD has to add to the next panel. This is the paired IGF-1 plus IGFBP-3 interpretation guide for the sports RD: the GH-receptor-to-JAK2-STAT5 biology that drives the dissociated storage-versus-synthesis signal, the age-decade reference brackets, the four paired-draw patterns that classify the GH-IGF-1 axis, the four athlete-population presentations that earn the ordered paired draw, the paired-panel assembly against the free-T3-and-gonadal-axis RED-S differential, the SOAP structure that carries the finding into the energy-availability, training-load, and sports-endocrinology-referral branches of the plan, and the eight-to-twelve-week follow-on redraw cadence that tracks the recovery trajectory against the pattern-specific intervention.
November 19, 2026